Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 14, 2025
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
GlobeNewswire
·
April 14, 2025
RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution designed to help biopharmaceutical companies lead the …
AITX's RAD Builds Upon Urban Safety Momentum with Key Deployments in Major Cities
GlobeNewswire
·
April 14, 2025
Cities Turn to RAD for Smarter, AI-Powered Public Safety Solutions Detroit, Michigan, April 14, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity …
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September
GlobeNewswire
·
April 14, 2025
-- Trial Read-Out Data Expected in Early 2026 -- CALABASAS, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system …
Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs
GlobeNewswire
·
April 14, 2025
PITTSBURGH, Pa. …
First Trillion-Dollar Ready RWA Platform: IOST Partners with DigiFT for Institutional-Grade Tokenization
GlobeNewswire
·
April 14, 2025
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- IOST, a high-performance blockchain infrastructure provider, has announced a partnership with DigiFT, Singapore’s first MAS-licensed digital asset exchange, to offer institutional-grade investment opportunities …
Can-Fite Reports 2024 Financial Results and Clinical Update
GlobeNewswire
·
April 14, 2025
RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …
Wrapsody eCo Strengthens Data Protection and Secure Collaboration Across Diverse Industries
EIN Presswire
·
April 14, 2025
SEOUL, SOUTH KOREA, April 14, 2025 /EINPresswire.com/ -- As organizations across industries increasingly rely on digital collaboration, the need for secure and efficient document management has never been greater. Fasoo’s next-generation secure …
Unisize, a sizing recommendation software for fashion apparel e-commerce, releases a new demo of “FaceChange” AI Function
GlobeNewswire
·
April 14, 2025
LONDON, April 14, 2025 (GLOBE NEWSWIRE) -- Makip London., Ltd. has updated its sizing recommendation software - Unisize - and released a new feature that allows online shoppers to replace the facial features of the online model with their own face, …
TopBuilder Announces Integration With BuildingConnected
GlobeNewswire
·
April 14, 2025
HOUSTON, April 14, 2025 (GLOBE NEWSWIRE) -- TopBuilder, a leading business development platform and CRM software for contractors in commercial construction, is excited to announce a new integration with BuildingConnected®, a pre-construction solution that …
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness
GlobeNewswire
·
April 14, 2025
Stevenage, UK, and Boca Raton, Florida, US, April 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system has partnered with the Cell and …
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
GlobeNewswire
·
April 14, 2025
FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, welcomes action by the Centers for Medicare …
NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
GlobeNewswire
·
April 14, 2025
SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
GlobeNewswire
·
April 14, 2025
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
FOREWARN to Provide Identity Verification Services to HiCentral MLS® to Promote Agent Safety
GlobeNewswire
·
April 14, 2025
BOCA RATON, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that HiCentral MLS® will offer FOREWARN® services to …
MKS Instruments Announces First Quarter 2025 Earnings Conference Call
GlobeNewswire
·
April 14, 2025
ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2025 financial results after market …
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
GlobeNewswire
·
April 14, 2025
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical safety and activity data from ongoing …
Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
GlobeNewswire
·
April 14, 2025
– $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI®, a revenue- …
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
GlobeNewswire
·
April 14, 2025
Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced expected revenue and …
Western Uranium & Vanadium Corp. Announces Ore Purchase Agreement
GlobeNewswire
·
April 14, 2025
Toronto, Ontario and Nucla, Colorado, April 14, 2025 (GLOBE NEWSWIRE) -- Western Uranium …
Bitcoin 2.0: BloomBeans Offers $150M Airdrop for a New Economic Foundation
GlobeNewswire
·
April 14, 2025
Lisbon, Portugal, April 14, 2025 (GLOBE NEWSWIRE) -- BloomBeans.io is releasing the first decentraliced financial system to substitute Bitcoin. A New Global Financial System Lead by Takashi Nakamoto and designed by Austrian economists, BloomBeans operates …